← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novasite Pharmaceuticals, Inc.
San Diego, CA
$9,510,988
Total funding
11
Grants
Funding over time
peak $1.6M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$9,510,988 · 11
By mechanism
R01$5,302,762 · 2
R44$3,132,033 · 3
R43$998,942 · 5
R29$77,251 · 1
Investigators at Novasite Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
DRUG DISCOVERY OF LARGE-SCALE VARIANT TARGETS BY HTS$1,720,981
R01 · FY2000 · AI
Split-Maze Discovery of Antiobesity Drugs$1,432,975
R44 · FY2002 · DK
Single Cell Multiplex Screening of Protein Families$1,133,906
R01 · FY2005 · EB
Single Cell Multiplex Screening of Protein Families$944,279
R01 · FY2004 · EB
Split-Maze Discovery of Antiobesity Drugs$933,335
R44 · FY2003 · DK
DRUG DISCOVERY OF LARGE-SCALE VARIANT TARGETS BY HTS$762,908
R01 · FY2002 · AI
DRUG DISCOVERY OF LARGE-SCALE VARIANT TARGETS BY HTS$740,688
R01 · FY2001 · AI
Purified Serotonin Receptors for Structural Studies$505,717
R44 · FY2005 · MH
Crystallization of the human cannabinoid type 2 receptor$260,006
R44 · FY2006 · DA
5HT2 Selective Ligands Guided by Receptor Variants$250,001
R43 · FY2003 · DA
Purification of Cannabinoid Receptors Type 1 and 2$250,001
R43 · FY2003 · DA
Human Tissue Cell-Based Toxicity by Flow Cytometry$250,000
R43 · FY2003 · CA
Purified Serotonin Receptors for Structural Studies$148,940
R43 · FY2003 · MH
SPLIT-MAZE DISCOVERY OF ANTIOBESITY DRUGS$100,000
R43 · FY2000 · DK
CONTROL OF HEART MITOCHONDRIAL NADH BY WORK AND CA++$77,251
R29 · FY2001 · HL